Back
From Pilot to Implementation: Bupa’s Use of Genomics for Personalised, Preventive Care
Wednesday, January 27, 2027 at 3:30 PM to 4:00 PM · 30 min. (Europe/London)
Pharmacogenomics & Patient Stratification Stage
Day 1 - Wednesday 27th January
Precision Medicine
Information
Outcomes from a 16,000-person WGS global pilot for Pharmacogenomics and PRS
Integrating Medication Check, polygenic risk scores (PRS) and monogenic tests into clinical pathways
The impact of being the first UK insurer to fund preventive treatment.
Speakers
Rebecca Rohrer
Clinical Innovation and Genomics Director
Bupa